Pay in 4 interest-free payments of $7.41 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
"Safe medical treatment for obesity is still in its infancy and we need to understand fully how the treatment works
Zepbound is in a class of its own as the only FDA-approved dual GIP and GLP-1 receptor agonist obesity medication, and its changing how millions of people manage this chronic disease. In the US, tirzepatide is marketed as Zepbound for obesity and weight loss treatment, and as Mounjaro for type 2 diabetes
The treatment works best as part of a longer strategy focused on health, body composition, and sustainable habits
Simply put, drugs like Ozempic act like the GLP-1 hormone, so they can make us feel fuller for longer, impact insulin production, and trigger other responses that can, as a result, induce weight loss
approximately 50% lost 10% or more of baseline weight, while roughly 25% lost 5-10%
US$ 26.83
US$ 20.29
US$ 29.09
US$ 28.44
US$ 28.85
